Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ejhf.2802 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to Saleh, C.; Budincevic, H. Interleukin-6, Tocilizumab and Atherosclerosis. Comment on "Gerasimova et al. Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. 2024, , 12425".
Int J Mol Sci
March 2025
Department of Systemic Rheumatic Diseases, V.A. Nasonova Research Institute of Rheumatology, Kashirskoe Shosse, 115522 Moscow, Russia.
We thank the authors for their interest in our study [...
View Article and Find Full Text PDFReply to 'Interleukin-6 in acute heart failure: it does work, but how much?'.
Eur J Heart Fail
April 2023
Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, Basel, Switzerland.
Reply: COVID-19 drug research and the cohort multiple randomised controlled trial design.
Eur Respir J
September 2022
Département d'Hématologie, Hôpital Necker, AP-HP, Université de Paris, Paris, France
https://bit.ly/39Obd4N
View Article and Find Full Text PDFReply to "Comments on: Acute aerobic exercise-conditioned serum reduces colon cancer cell proliferation in vitro through interleukin-6-induced regulation of DNA damage".
Int J Cancer
November 2022
Department of Sport, Exercise and Rehabilitation, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
Reply to letter to the editor: "Interleukin-6 level, right ventricular systolic dysfunction, and coronavirus disease 2019".
Anatol J Cardiol
February 2022
Departments of Infectious Disease and Clinical Microbiology, Faculty of Medicine, Ankara Yıldırım Beyazıt University; Ankara-Turkey.